- Home
- JAGX vs PSTV Comparison
JAGX vs PSTV Comparison
Compare JAGX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- PSTV
- Stock Information
- Founded
- JAGX 2013
- PSTV 1996
- Country
- JAGX United States
- PSTV United States
- Employees
- JAGX N/A
- PSTV N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- PSTV Medical/Dental Instruments
- Sector
- JAGX Health Care
- PSTV Health Care
- Exchange
- JAGX Nasdaq
- PSTV Nasdaq
- Market Cap
- JAGX 9.6M
- PSTV 7.9M
- IPO Year
- JAGX N/A
- PSTV N/A
- Fundamental
- Price
- JAGX $0.94
- PSTV $1.17
- Analyst Decision
- JAGX
- PSTV Strong Buy
- Analyst Count
- JAGX 0
- PSTV 2
- Target Price
- JAGX N/A
- PSTV $14.00
- AVG Volume (30 Days)
- JAGX 304.8K
- PSTV 101.8K
- Earning Date
- JAGX 11-13-2024
- PSTV 11-14-2024
- Dividend Yield
- JAGX N/A
- PSTV N/A
- EPS Growth
- JAGX N/A
- PSTV N/A
- EPS
- JAGX N/A
- PSTV N/A
- Revenue
- JAGX $10,480,000.00
- PSTV $5,509,000.00
- Revenue This Year
- JAGX $32.33
- PSTV $11.13
- Revenue Next Year
- JAGX $43.63
- PSTV N/A
- P/E Ratio
- JAGX N/A
- PSTV N/A
- Revenue Growth
- JAGX N/A
- PSTV 113.20
- 52 Week Low
- JAGX $0.90
- PSTV $1.15
- 52 Week High
- JAGX $30.84
- PSTV $2.78
- Technical
- Relative Strength Index (RSI)
- JAGX 40.43
- PSTV 40.41
- Support Level
- JAGX $0.95
- PSTV $1.17
- Resistance Level
- JAGX $1.20
- PSTV $1.42
- Average True Range (ATR)
- JAGX 0.09
- PSTV 0.11
- MACD
- JAGX -0.00
- PSTV -0.01
- Stochastic Oscillator
- JAGX 23.40
- PSTV 15.63
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).